Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ResMed Inc (RMD)

  • Business News
  • Jan. 15, 2026, 23:26 UTC
  • 5
  • 1 comments

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

Chemours Co (CC)

  • Business News
  • Jan. 15, 2026, 22:01 UTC
  • 5
  • 1 comments

The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan

Market reaction Comment Full text

Emergent Biosolutions Inc. (EBS)

  • Business News
  • Jan. 15, 2026, 22:00 UTC
  • 5
  • 1 comments

Emergent Announces Resolution of New York Attorney General Investigation

Market reaction Comment Full text

Briacell Therapeutics Corp (BCTX)

  • Business News
  • Jan. 15, 2026, 21:44 UTC
  • 5
  • 1 comments

Notification from BriaCell Therapeutics Corp.

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Jan. 15, 2026, 21:36 UTC
  • 4
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Jan. 15, 2026, 21:16 UTC
  • 6
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

Laboratory Corporation of America Holdings (LH)

  • Business News
  • Jan. 15, 2026, 21:15 UTC
  • 5
  • 1 comments

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

Market reaction Comment Full text

Oncolytics Biotech Inc (ONCY)

  • Business News
  • Jan. 15, 2026, 21:12 UTC
  • 5
  • 1 comments

A New Press Release from Oncolytics Biotech, Inc

Market reaction Comment Full text

Veradigm Inc (MDRX)

  • Business News
  • Jan. 15, 2026, 21:01 UTC
  • 6
  • 1 comments

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

Market reaction Comment Full text

Penumbra Inc (PEN)

  • Business News
  • Jan. 15, 2026, 20:30 UTC
  • 5
  • 1 comments

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

Market reaction Comment Full text
  • Previous
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next

Search

News categories

  • Technical Exchange News(10847)
  • Event(2204)
  • SEC News(187843)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124273)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin